Expressão e caracterização de proteína de envelope gp140 do HIV pelo vírus da Febre Amarela 17D

Mello, Iasmim Silva de.
Rio de Janeiro; s.n; 2017. 79 p. ilus.
Tesis en Portugués | BVSDIP, FIOCRUZ | ID: dip-4160

Documentos relacionados

  1. Yellow fever vaccine hesitancy and its relationship with contextual, individual, or group influences and vaccine-specific issues: a scoping review.
  2. Reply to Adler et al.
  3. Process intensification for the production of yellow fever virus-like particles as potential recombinant vaccine antigen.
  4. YF17D-based vaccines - standing on the shoulders of a giant.
  5. Frequency of allergic reactions in egg allergic patients after receiving the yellow fever vaccine.
  6. Innovative in cellulo method as an alternative to in vivo neurovirulence test for the characterization and quality control of human live Yellow Fever virus vaccines: A pilot study.
  7. Brain-wide circuit-specific targeting of astrocytes.
  8. Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial.
  9. Evaluation of hydrogen peroxide virucidal efficacy against yellow fever virus 17DD vaccine strain for application in a vaccine manufacturing industry.
  10. Performance assessment and validation of a plaque reduction neutralization test (PRNT) in support to yellow fever diagnostic and vaccine clinical trials.